- Home
- CVAC vs BDN Comparison
CVAC vs BDN Comparison
Compare CVAC & BDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- BDN
- Stock Information
- Founded
- CVAC 2000
- BDN 1986
- Country
- CVAC Germany
- BDN United States
- Employees
- CVAC N/A
- BDN N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- BDN Real Estate Investment Trusts
- Sector
- CVAC Health Care
- BDN Real Estate
- Exchange
- CVAC Nasdaq
- BDN Nasdaq
- Market Cap
- CVAC 818.8M
- BDN 799.6M
- IPO Year
- CVAC 2020
- BDN N/A
- Fundamental
- Price
- CVAC $3.12
- BDN $3.78
- Analyst Decision
- CVAC Buy
- BDN Hold
- Analyst Count
- CVAC 2
- BDN 1
- Target Price
- CVAC $10.00
- BDN $5.00
- AVG Volume (30 Days)
- CVAC 717.4K
- BDN 2.9M
- Earning Date
- CVAC 04-10-2025
- BDN 04-22-2025
- Dividend Yield
- CVAC N/A
- BDN 15.87%
- EPS Growth
- CVAC N/A
- BDN N/A
- EPS
- CVAC 0.75
- BDN N/A
- Revenue
- CVAC $554,073,921.00
- BDN $313,998,000.00
- Revenue This Year
- CVAC N/A
- BDN $57.03
- Revenue Next Year
- CVAC $66.34
- BDN $3.55
- P/E Ratio
- CVAC $4.19
- BDN N/A
- Revenue Growth
- CVAC 895.54
- BDN N/A
- 52 Week Low
- CVAC $2.22
- BDN $3.41
- 52 Week High
- CVAC $5.28
- BDN $6.54
- Technical
- Relative Strength Index (RSI)
- CVAC 53.48
- BDN 35.39
- Support Level
- CVAC $3.05
- BDN $3.41
- Resistance Level
- CVAC $3.02
- BDN $3.84
- Average True Range (ATR)
- CVAC 0.19
- BDN 0.23
- MACD
- CVAC 0.06
- BDN -0.01
- Stochastic Oscillator
- CVAC 79.14
- BDN 33.33
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About BDN Brandywine Realty Trust
Brandywine Realty Trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of a portfolio of office, life science/lab, residential, and mixed-use properties. The company owned and managed properties within five segments. The Philadelphia CBD segment includes properties located in the City of Philadelphia in Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware and Montgomery counties in the Philadelphia suburbs. The Austin, Texas segment includes properties in the City of Austin, Texas. The Metropolitan Washington, D.C. segment includes properties in Northern Virginia, Washington, D.C. and Southern Maryland. The Other segment includes properties in Camden County, New Jersey and New Castle County, Delaware.